Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

Bullboard (TSX:TH)

View:
Comment by Maxmoeon Dec 02, 2024 1:48am

RE:RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Whoever came up with "thought leader liaison" should be fired. Got a chuckle it's a west coast position. Vs the nyc and Ohio jobs that underneath the sanitation engineering descriptions ...more  
Comment by SPCEO1on Nov 27, 2024 4:45pm

RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Here are three positions THTX is currently hiring as indicated on LinkedIn. It would be odd if they were hiring people in the face of a complete loss of Egrifta revenue in Q1 without something else ...more  
Comment by Kd5513on Nov 27, 2024 3:19pm

RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

The Exec's will get their bonuses stealing another 5-10% of value from mkt cap (Paul has taken in from salary, bonus, options what 35% of current mkt cap? Such a genius from Pfizer. Marathon ...more  
Comment by Trogarzonon Nov 27, 2024 2:16pm

RE:RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Anyway in the end Th1902 is the only reason any of us have been hanging on to the stock. I don't care for their specialised distribution business apart of the fact it keeps the company alive.
Comment by Trogarzonon Nov 27, 2024 2:07pm

RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

It appears from the fact they haven't put out an update or what.   Our CFO was CONFIDENT last time he spoke about it in the Q3 call.  If so once again it was BS.
Comment by SPCEO1on Nov 27, 2024 1:53pm

RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Had THTX got F8 approved in January, the Egrifta shortage situation would not have been a meaningful event at all as most patients would already be on F8. Now, it appears THTX will likely go the whole ...more  
Comment by Lee430on Nov 27, 2024 11:45am

RE:RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Thera, It’s tax loss harvesting season again so this sure would be a good time to maybe consider engaging with the market before we break below $1.0
Comment by PWIB123on Nov 26, 2024 10:54am

RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Never in my life have I seen a company so bad at public communication.  
Comment by PWIB123on Nov 26, 2024 10:53am

RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

Nope.  You heard correctly.  They have set a precedence that we cannot trust a word that comes out of their mouth.  Even if they simply provided interim updates, that would enhance ...more  
Comment by PWIB123on Nov 26, 2024 10:49am

RE:RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

I'm feeling the same sense of frustration as you.  I remember reading that this new formula really won't help sales, but am I recalling correctly that it will help extend the patent ...more  
Comment by Joemareon Nov 26, 2024 8:54am

RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

10 months to reply to a submission they thought was a walk in the park.  It means they had to redo many of what was required.   Anyways, at least they pushed it out before they fiscal ...more  
Comment by Trogarzonon Nov 26, 2024 8:46am

RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review

If the same applies to our Egrifta shortage we'll be out of our investment money in 10 months and IQ will own the company.  They'll probably celebrate with the C-Suite and linkedin the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities